These findings indicate that impairment of the Ca2+-sensitivity pathway, especially the CPI-17/MLCP pathway in intestinal smooth muscle played a role in the pathogenesis of intestinal dysmotility in experimental AP. This evidence concerns the gene PPP1R14A and alkaline phosphatase measurement.